BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 11748645)

  • 21. The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours.
    Ramani P; Cowell JK
    J Pathol; 1996 Jun; 179(2):162-8. PubMed ID: 8758208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-expression of VEGF, c-Met and HGF/SF in secondary pleural tumors.
    Naim R; Tolnay E; Mueller KM; Kuhnen C
    Int J Mol Med; 2004 Nov; 14(5):787-91. PubMed ID: 15492846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
    Schulz S; Becker KF; Braungart E; Reichmuth C; Klamt B; Becker I; Atkinson M; Gessler M; Höfler H
    J Pathol; 2000 Jun; 191(2):162-9. PubMed ID: 10861576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of hepatocyte growth factor and its receptor c-Met in nasal polyps.
    Rho HS; Lee SH; Lee HM; Lee SH; Jung HH; Choi J; Park MK; Kang SM
    Arch Otolaryngol Head Neck Surg; 2006 Sep; 132(9):985-9. PubMed ID: 16982975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.
    Eccles MR; Wallis LJ; Fidler AE; Spurr NK; Goodfellow PJ; Reeve AE
    Cell Growth Differ; 1992 May; 3(5):279-89. PubMed ID: 1378753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
    Kim CH; Moon SK; Bae JH; Lee JH; Han JH; Kim K; Choi EC
    Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the N-myc oncogene in Wilms' tumour and related tissues.
    Shaw AP; Poirier V; Tyler S; Mott M; Berry J; Maitland NJ
    Oncogene; 1988 Aug; 3(2):143-9. PubMed ID: 2842712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor. An in situ hybridization study.
    Paik S; Rosen N; Jung W; You JM; Lippman ME; Perdue JF; Yee D
    Lab Invest; 1989 Nov; 61(5):522-6. PubMed ID: 2554059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-6- and tumour necrosis factor alpha-mediated expression of hepatocyte growth factor by stromal cells and its involvement in the growth of endometriosis.
    Khan KN; Masuzaki H; Fujishita A; Kitajima M; Hiraki K; Sekine I; Matsuyama T; Ishimaru T
    Hum Reprod; 2005 Oct; 20(10):2715-23. PubMed ID: 16006475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
    Yun K; Fidler AE; Eccles MR; Reeve AE
    Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met.
    Onimaru Y; Tsukasaki K; Murata K; Imaizumi Y; Choi YL; Hasegawa H; Sugahara K; Yamada Y; Hayashi T; Nakashima M; Taguchi T; Mano H; Kamihira S; Tomonaga M
    Int J Oncol; 2008 Oct; 33(4):697-703. PubMed ID: 18813782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity.
    Liang H; O'Reilly S; Liu Y; Abounader R; Laterra J; Maher VM; McCormick JJ
    Int J Oncol; 2004 May; 24(5):1057-67. PubMed ID: 15067326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the neurotrophin receptors p75 and trk in a series of Wilms' tumors.
    Donovan MJ; Hempstead B; Huber LJ; Kaplan D; Tsoulfas P; Chao M; Parada L; Schofield D
    Am J Pathol; 1994 Oct; 145(4):792-801. PubMed ID: 7943171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.
    Ferracini R; Di Renzo MF; Scotlandi K; Baldini N; Olivero M; Lollini P; Cremona O; Campanacci M; Comoglio PM
    Oncogene; 1995 Feb; 10(4):739-49. PubMed ID: 7862451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of MIB and BCL-2 in patients with nephrogenic rests with and without associated Wilms' tumors.
    Wünsch L; Flemming P; Glüer S
    Eur J Pediatr Surg; 2001 Apr; 11(2):105-9. PubMed ID: 11371029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte growth factor (HGF) receptor expression and role of HGF during embryonic mouse testis development.
    Ricci G; Catizone A; Innocenzi A; Galdieri M
    Dev Biol; 1999 Dec; 216(1):340-7. PubMed ID: 10588883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of the c-met proto-oncogene product in normal skin and tumours of melanocytic origin.
    Saitoh K; Takahashi H; Sawada N; Parsons PG
    J Pathol; 1994 Nov; 174(3):191-9. PubMed ID: 7823252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Met protein in thyroid tumours.
    Ruco LP; Ranalli T; Marzullo A; Bianco P; Prat M; Comoglio PM; Baroni CD
    J Pathol; 1996 Nov; 180(3):266-70. PubMed ID: 8958803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wilms' tumour as a paradigm for the relationship of cancer to development.
    Pritchard-Jones K; Hastie ND
    Cancer Surv; 1990; 9(3):555-78. PubMed ID: 1966278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
    Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.